HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by van den Born, E. Articles by Snijder, E. J. Search for Related Content PubMed PubMed Citation Articles by van den Born, E. Articles by Snijder, E. J. Agricola Articles by van den Born, E. Articles by Snijder, E. J.

Antiviral activity of morpholino oligomers designed to block various aspects of Equine arteritis virus amplification in cell culture

¹ Molecular Virology Laboratory, Department of Medical Microbiology, Center of Infectious Diseases, Leiden University Medical Center, LUMC P4-26, PO Box 9600, 2300 RC Leiden, The Netherlands
² AVI BioPharma Inc., 4575 SW Research Way, Corvallis, OR 97333, USA

Correspondence
Eric J. Snijder
e.j.snijder{at}lumc.nl

The antiviral efficacy of ten antisense phosphorodiamidate morpholino oligomers (PMOs) directed against Equine arteritis virus (EAV), a nidovirus belonging to the family Arteriviridae, was evaluated in mammalian (Vero-E6) cells. Peptide-conjugated PMOs (P-PMOs) supplied in cell culture medium at micromolar concentrations were efficiently taken up by Vero-E6 cells and were minimally cytotoxic. The P-PMOs were designed to base pair to RNA sequences involved in different aspects of EAV amplification: genome replication, subgenomic mRNA synthesis, and translation of genome and subgenomic mRNAs. A novel recombinant EAV, expressing green fluorescent protein as part of its replicase polyproteins, was used to facilitate drug screening. A moderate reduction of EAV amplification was observed with relatively high concentrations of P-PMOs designed to anneal to the 3'-terminal regions of the viral genome or antigenome. To determine if the synthesis of subgenomic mRNAs could be specifically reduced, transcription-regulating sequences essential for their production, but not for the production of genomic RNA, were targeted, but these P-PMOs were found to be ineffective at transcription interference. In contrast, all four P-PMOs designed to base pair with targets in the genomic 5' untranslated region markedly reduced virus amplification in a sequence-specific and dose-responsive manner. At concentrations in the low micromolar range, some of the P-PMOs tested completely inhibited virus amplification. In vitro translation assays showed that these P-PMOs were potent inhibitors of translation. The data suggest that these compounds could be useful as reagents for exploring the molecular mechanics of nidovirus translation and have anti-EAV potential at relatively low concentrations.

This article has been cited by other articles:

				J. K. Stone, R. Rijnbrand, D. A. Stein, Y. Ma, Y. Yang, P. L. Iversen, and R. Andino A Morpholino Oligomer Targeting Highly Conserved Internal Ribosome Entry Site Sequence Is Able To Inhibit Multiple Species of Picornavirus Antimicrob. Agents Chemother., June 1, 2008; 52(6): 1970 - 1981. [Abstract] [Full Text] [PDF]

				Y.-J. Zhang, R. S. Bonaparte, D. Patel, D. A. Stein, and P. L. Iversen Blockade of viral interleukin-6 expression of Kaposi's sarcoma-associated herpesvirus Mol. Cancer Ther., March 1, 2008; 7(3): 712 - 720. [Abstract] [Full Text] [PDF]

				A. Vagnozzi, D. A. Stein, P. L. Iversen, and E. Rieder Inhibition of Foot-and-Mouth Disease Virus Infections in Cell Cultures with Antisense Morpholino Oligomers J. Virol., November 1, 2007; 81(21): 11669 - 11680. [Abstract] [Full Text] [PDF]

				T. S. Deas, C. J. Bennett, S. A. Jones, M. Tilgner, P. Ren, M. J. Behr, D. A. Stein, P. L. Iversen, L. D. Kramer, K. A. Bernard, et al. In Vitro Resistance Selection and In Vivo Efficacy of Morpholino Oligomers against West Nile Virus Antimicrob. Agents Chemother., July 1, 2007; 51(7): 2470 - 2482. [Abstract] [Full Text] [PDF]

				R. Burrer, B. W. Neuman, J. P. C. Ting, D. A. Stein, H. M. Moulton, P. L. Iversen, P. Kuhn, and M. J. Buchmeier Antiviral Effects of Antisense Morpholino Oligomers in Murine Coronavirus Infection Models J. Virol., June 1, 2007; 81(11): 5637 - 5648. [Abstract] [Full Text] [PDF]

				E. van den Born, C. C. Posthuma, K. Knoops, and E. J. Snijder An infectious recombinant equine arteritis virus expressing green fluorescent protein from its replicase gene J. Gen. Virol., April 1, 2007; 88(4): 1196 - 1205. [Abstract] [Full Text] [PDF]

				N. Tamberg, V. Lulla, R. Fragkoudis, A. Lulla, J. K. Fazakerley, and A. Merits Insertion of EGFP into the replicase gene of Semliki Forest virus results in a novel, genetically stable marker virus J. Gen. Virol., April 1, 2007; 88(4): 1225 - 1230. [Abstract] [Full Text] [PDF]

				J. Yuan, D. A. Stein, T. Lim, D. Qiu, S. Coughlin, Z. Liu, Y. Wang, R. Blouch, H. M. Moulton, P. L. Iversen, et al. Inhibition of Coxsackievirus B3 in Cell Cultures and in Mice by Peptide-Conjugated Morpholino Oligomers Targeting the Internal Ribosome Entry Site J. Virol., December 1, 2006; 80(23): 11510 - 11519. [Abstract] [Full Text] [PDF]

				Q. Ge, M. Pastey, D. Kobasa, P. Puthavathana, C. Lupfer, R. K. Bestwick, P. L. Iversen, J. Chen, and D. A. Stein Inhibition of Multiple Subtypes of Influenza A Virus in Cell Cultures with Morpholino Oligomers Antimicrob. Agents Chemother., November 1, 2006; 50(11): 3724 - 3733. [Abstract] [Full Text] [PDF]